Article
Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.
International journal of clinical pharmacy - 1 Dec 2015
Kim Jae Hee, Jung Seok Won, Byun Sung Soo, Shin Jung Woo, Park Bo Ryung, Kim Min-Ho, Kim Chang Jae, Park Neung Hwa
Abstract excerpt
BACKGROUND: Tenofovir disoproxil fumarate (TDF) has demonstrated potent antiviral activity against hepatitis B virus (HBV) in clinical trials. Although its efficacy has been demonstrated in Caucasian populations, TDF has not previously been studied in Korean patients who present the predominance of HBV genotype C and of vertical or perinatal transmission. OBJECTIVE: The aim of this study was to evaluate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
